Treat, a Finnish healthtech company, has announced a €3 million pre-seed funding round led by byFounders—an early investor in Lovable—alongside Illusian, the venture fund backed by Supercell founder Ilkka Paananen. The platform pairs AI-driven patient intake with consultations from qualified physicians, aiming to reduce superfluous appointments and enhance care accessibility.

The service works by connecting patients with doctors within minutes, with physicians having already reviewed relevant medical context before the consultation begins. This approach eliminates the need for unnecessary visits and removes the misaligned financial incentives that plague the private healthcare sector.

The Economics of Inefficiency in Private Care

Private healthcare systems typically operate on a volume-based model where clinics generate revenue through the quantity of appointments and follow-up visits. This structure often leaves physicians without adequate time to examine patient histories, while patients experience what amounts to a series of disconnected diagnostic consultations. Treat proposes an alternative approach to this dynamic.

The platform leverages intelligent intake processes to organize symptom information and allows doctors sufficient time to examine relevant medical history prior to consultation. This methodology enables most cases to be resolved through a single digital visit, with remaining cases directed immediately to the appropriate specialist.

Treat was founded by Sami Marttinen, former chief executive of Swappie; Antti Mauno, a licensed physician; and Onni Wahlberg, a fintech engineering specialist.

Marttinen's motivation stems from personal experience. "Three years ago, my wife had to go through nine repeat doctor visits in private care before receiving a diagnosis. All the necessary information existed, but nobody had the incentive to connect the dots," he explains.

The problem isn't the doctors. It's an economic model that rewards repeat visits over efficient resolution. Treat makes zero revenue from lab tests, clinic visits, or referrals. Our only incentive is solving the patient's issue on the spot.

Sami Marttinen, CEO of Treat

AI for Administration, Physicians for Clinical Care

Treat deploys artificial intelligence exclusively to reduce administrative burden. Patients articulate their symptoms in natural language, and an adaptive intake mechanism transforms this into a structured summary. The platform ensures that patient records and personally identifiable information remain isolated from public language models, with licensed doctors maintaining sole authority over medical data access and all clinical decision-making.

Sara Rywe, General Partner at byFounders, commented on the investment: "Private healthcare across the globe is bogged down by fragmented systems and mismatched incentives. Treat fixes this at the root. By stripping away billable runarounds and aligning technology directly with clinical workflows, the team behind Treat is building a new benchmark for primary care."

Treat reaches users through employer-sponsored programs, functioning as a supplement to existing private health insurance and occupational healthcare offerings. The arrangement provides workers with immediate access to a physician who has already reviewed their case, while simultaneously reducing unnecessary consultations and helping employers manage healthcare expenditure.

Source: Tech.eu